Mannich bases are the end products of Mannich reaction and are known as beta-amino ketone carrying compounds. Mannich reaction is a carbon-carbon bond forming nucleophilic addition reaction and is a key step in synthesis of a wide variety of natural products, pharmaceuticals, and so forth. Mannich reaction is important for the construction of nitrogen containing compounds. There is a number of aminoalkyl chain bearing Mannich bases like fluoxetine, atropine, ethacrynic acid, trihexyphenidyl, and so forth with high curative value. The literature studies enlighten the fact that Mannich bases are very reactive and recognized to possess potent diverse activities like anti-inflammatory, anticancer, antifilarial, antibacterial, antifungal, anticonvulsant, anthelmintic, antitubercular, analgesic, anti-HIV, antimalarial, antipsychotic, antiviral activities and so forth. The biological activity of Mannich bases is mainly attributed to α, β-unsaturated ketone which can be generated by deamination of hydrogen atom of the amine group. 1. Introduction Mannich bases, beta-amino ketones carrying compounds, are the end products of Mannich reaction [1, 2]. Mannich reaction is a nucleophilic addition reaction which involves the condensation of a compound with active hydrogen(s) with an amine (primary or secondary) and formaldehyde (any aldehyde) [3]. The schematic representation of general Mannich reaction is given in Scheme 1. Scheme 1 Mannich bases also act as important pharmacophores or bioactive leads which are further used for synthesis of various potential agents of high medicinal value which possess aminoalkyl chain. The examples of clinically useful Mannich bases which consist of aminoalkyl chain are cocaine, fluoxetine, atropine, ethacrynic acid, trihexyphenidyl, procyclidine, ranitidine, biperiden [4–6], and so forth. Mannich bases are known to play a vital role in the development of synthetic pharmaceutical chemistry. The literature studies revealed that Mannich bases are very reactive and can be easily converted to other compounds, for example, reduced to form physiologically active amino alcohols [7]. Mannich bases are known to possess potent activities like anti-inflammatory [8, 9], anticancer [10, 11], antifilarial [8], antibacterial [12, 13], antifungal [13, 14], anticonvulsant [15], anthelmintic [16], antitubercular [17, 18], analgesic [19], anti-HIV [17], antimalarial [20], antipsychotic [21], antiviral [22] activities and so forth. Along with biological activities Mannich bases are also known for their uses in detergent additives [23], resins,
References
[1]
Advanced Organic Chemistry: Reactions, Mechanisms, and Structure, John Wiley & Sons, New York, NY, USA, 3rd edition, 1985.
[2]
V. J. Belinelo, G. T. Reis, G. M. Stefani, D. L. Ferreira-Alves, and D. Piló-Veloso, “Synthesis of 6α,7β-dihydroxyvouacapan-17β-oic acid derivatives. Part IV: mannich base derivatives and its activities on the electrically stimulated guinea-pig ileum preparation,” Journal of the Brazilian Chemical Society, vol. 13, no. 6, pp. 830–837, 2002.
[3]
S. Joshi, N. Khosla, and P. Tiwari, “In vitro study of some medicinally important Mannich bases derived from anti-tubercular agent,” Bioorganic & Medicinal Chemistry, vol. 12, no. 3, pp. 571–576, 2004.
[4]
L. Racane, V. T. Kulenovic, L. F. Jakic, D. W. Boykin, and G. K. Zamola, “Synthesis of bis -substituted amidino-benzothiazoles as potential anti-HIV agents,” Heterocycles, vol. 55, pp. 2085–2098, 2001.
[5]
E. Kashiyama, I. Hutchinson, M.-S. Chua et al., “Antitumor benzothiazoles. 8.1 Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4- aminophenyl)-benzothiazoles,” Journal of Medicinal Chemistry, vol. 42, no. 20, pp. 4172–4184, 1999.
[6]
S. R. Bhusare, R. P. Pawar, and Y. B. Vibhute, “Synthesis and antibacterial activity of some new 2-(substituted phenyl sulfonamido)-6-substituted benzothiazoles,” Indian Journal of Heterocyclic Chemistry, vol. 11, no. 1, pp. 79–80, 2001.
[7]
N. Raman, S. Esthar, and C. Thangaraja, “A new Mannich base and its transition metal (II) complexes—synthesis, structural characterization and electrochemical study,” Journal of Chemical Sciences, vol. 116, no. 4, pp. 209–213, 2004.
[8]
B. Kalluraya, R. M. Chimbalkar, and J. C. Hegde, “Anticonvulsant activity of nicotinyl？isonicotinyl substituted 1,2,4-triazol-5-thione Mannich bases,” Indian Journal of Heterocyclic Chemistry, vol. 15, no. 1, pp. 15–18, 2005.
[9]
M. K？ksal, N. G？khan, E. Küpeli, E. Yesilada, and H. Erdogan, “Analgesic and antiinflammatory activities of some new Mannich bases of 5-nitro-2-benzoxazolinones,” Archives of Pharmacal Research, vol. 30, no. 4, pp. 419–424, 2007.
[10]
Y. Ivanova, G. Momekov, O. Petrov, M. Karaivanova, and V. Kalcheva, “Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones,” European Journal of Medicinal Chemistry, vol. 42, no. 11-12, pp. 1382–1387, 2007.
[11]
H. I. Gul, J. Vepsalainen, M. Gul, E. Erciyas, and O. Hanninen, “Cytotoxic activities of mono and bis Mannich bases derived from acetophenone against Renca and Jurkat cells,” Pharmaceutica Acta Helvetiae, vol. 74, no. 4, pp. 393–398, 2000.
[12]
M. Ashok, B. S. Holla, and B. Poojary, “Convenient one pot synthesis and antimicrobial evaluation of some new Mannich bases carrying 4-methylthiobenzyl moiety,” European Journal of Medicinal Chemistry, vol. 42, no. 8, pp. 1095–1101, 2007.
[13]
S. N. Pandeya, D. Sriram, G. Nath, and E. De Clercq, “Synthesis, antibacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases,” European Journal of Medicinal Chemistry, vol. 35, no. 2, pp. 249–255, 2000.
[14]
B. N. Singh, S. K. Shukla, and M. Singh, “Synthesis and biological activity of sulphadiazine Schiff's bases of isatin and their N-mannich bases,” Asian Journal of Chemistry, vol. 19, no. 7, pp. 5013–5018, 2007.
[15]
S. C. Vashishtha, G. A. Zello, K. H. Nienaber et al., “Cytotoxic and anticonvulsant aryloxyaryl Mannich bases and related compounds,” European Journal of Medicinal Chemistry, vol. 39, no. 1, pp. 27–35, 2004.
[16]
E. Bennet-Jenkins and C. Bryant, “Novel sources of anthelmintics,” International Journal for Parasitology, vol. 26, no. 8-9, pp. 937–947, 1996.
[17]
D. Sriram, D. Banerjee, and P. Yogeeswari, “Efavirenz Mannich bases: synthesis, anti-HIV and antitubercular activities,” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 24, no. 1, pp. 1–5, 2009.
[18]
J. S. Mulla, A. Y. Khan, S. I. Panchamukhi, M. A. Khazi, M. B. Kalashetti, and I. M. Khazi, “Synthesis and antitubercular activity of Mannich bases of imidazo [2,1-b] [1,3,4] thiadiazoles,” Indian Journal of Novel Drug Delivery, vol. 3, no. 4, pp. 289–295, 2011.
[19]
W. Malinka, P. ？wia？tek, B. Filipek, J. Sapa, A. Jezierska, and A. Koll, “Synthesis, analgesic activity and computational study of new isothiazolopyridines of Mannich base type,” Farmaco, vol. 60, no. 11-12, pp. 961–968, 2005.
[20]
G. B. Barlin and C. Jiravinya, “Potential antimalarials . X. Di- Mannich Bases of 4-(7'-Trifluoromethyl-1',5'-naphthyridin-4'-ylamino)phenol and N-(4'-Diethylamino-1'-methylbutyl)-7-trifluoromethyl-1,5-naphthyridin-4-amine,” Australian Journal of Chemistry, vol. 43, no. 7, pp. 1175–1181, 1990.
[21]
M. K. Scott, G. E. Martin, D. L. DiStefano, et al., “Pyrrole mannich bases as potential antipsychotic agents,” Journal of Medicinal Chemistry, vol. 35, no. 3, pp. 552–558, 1992.
[22]
M. L. Edwards, H. W. Ritter, D. M. Stemerick, and K. T. Stewart, “Mannich bases of 4-phenyl-3-buten-2-one: a new class of antiherpes agent,” Journal of Medicinal Chemistry, vol. 26, no. 3, pp. 431–436, 1983.
[23]
R. E. Karll and R. J. Lee, “Process and compositions,” US Patent no. 4,384,138, 1983.
[24]
F. P. Otto, US Patent, US 3 649 229, 1972.
[25]
J. R. Dimmock and P. Kumar, “Anticancer and cytotoxic properties of Mannich bases,” Current Medicinal Chemistry, vol. 4, no. 1, pp. 1–22, 1997.
[26]
J.-X. Ji, L.-Q. Qiu, C. Wing Yip, and A. S. C. Chan, “A convenient, one-step synthesis of optically active tertiary aminonaphthol and its applications in the highly enantioselective alkenylations of aldehydes,” The Journal of Organic Chemistry, vol. 68, no. 4, pp. 1589–1590, 2003.
[27]
P.-J. J. Huang, D. Youssef, T. S. Cameron, and A. Jha, “Microwave-assisted synthesis of novel 2-naphthol bis-Mannich Bases,” Arkivoc, vol. 2008, no. 16, pp. 165–177, 2008.
[28]
M. Arend, B. Westermann, and N. Risch, “Modern variants of the Mannich reaction,” Angewandte Chemie—International Edition, vol. 37, no. 8, pp. 1045–1070, 1998.
[29]
B. S. Holla, M. K. Shivananda, M. S. Shenoy, and G. Antony, “Studies on arylfuran derivatives. Part VII. Synthesis and characterization of some Mannich bases carrying halophenylfuryl moieties as promising antibacterial agents,” Farmaco, vol. 53, no. 8-9, pp. 531–535, 1998.
[30]
M. K. Shivananda and P. Prakash Shet, “Antifungal activity studies of some mannich bases carrying nitrofuran moiety,” Journal of Chemical and Pharmaceutical Research, vol. 3, no. 2, pp. 303–307, 2011.
[31]
A. Idhayadhulla, R. Surendra Kumar, A. Jamal Abdul Nasser, and A. Manilal, “Synthesis and antimicrobial activity of some new mannich base derivatives,” Journal of Chemical and Pharmaceutical Research, vol. 3, no. 4, pp. 904–911, 2011.
[32]
B. Lingappa, K. S. Girisha, B. Kalluraya, N. Satheesh Rai, and N. S. Kumari, “Regioselective reaction: synthesis of novel Mannich bases derived from 3-(4,6-disubstituted-2-thiomethylpyrimidyl)-4-amino-5-mercapto-1,2-4-triazoles and their antimicrobial properties,” Indian Journal of Chemistry—Section B Organic and Medicinal Chemistry, vol. 47, no. 12, pp. 1858–1864, 2008.
[33]
S. Bala, N. Sharma, A. Kajal, and S. Kamboj, “Design, synthesis, characterization, and computational studies on benzamide substituted mannich bases as novel, potential antibacterial agents,” The Scientific World Journal, vol. 2014, Article ID 732141, 9 pages, 2014.
[34]
P. P. Jumade, S. J. Wadher, A. J. Chourasia, U. V. Kharabe, D. Mude, and P. G. Yeole, “Synthesis of newer Mannich bases of quinoline derivative for antimicrobial activity,” International Journal of Chemical Sciences, vol. 7, no. 3, pp. 1518–1530, 2009.
[35]
S. Ravichandran and S. S. Kumar, “Synthesis, characterisation and antibacterial activity of Mannich base, N-[(1-piperidinobenzyl)]benzamide: a structure and reactivity study,” Asian Journal of Biochemical and Pharmaceutical Research, vol. 2, no. 1, pp. 136–142, 2011.
[36]
G. Madhu, K. N. Jayaveera, L. K. Ravindra Nath, B. Santosh Kumar, and P. Nagarjuna Reddy, “Synthesis and structure activity relationship of new antibacterial active multi substituted quinoline-azetidinone mannich bases,” Der Pharma Chemica, vol. 4, no. 3, pp. 1033–1040, 2012.
[37]
U. K. Singh, S. N. Pandeya, A. Singh, B. K. Srivastava, and M. Pandey, “Synthesis and antimicrobial activity of Schiff's and N-Mannich bases of isatin and its derivatives with 4-amino-n-carbamimidoyl benzene sulphonamide,” International Journal of Pharmaceutical Sciences and Drug Research, vol. 2, no. 2, pp. 151–154, 2010.
[38]
M. Vijey Aanandhi, A. K. Verma, R. Sujatha, and R. Kamal Raj, “Synthesis and characterization of novel mannich bases of benzimidazole derivatives for antibacterial and antifungal activity,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 5, no. 2, pp. 295–297, 2013.
[39]
S. A. Pishawikar and H. N. More, “Synthesis, docking and in-vitro screening of mannich bases of thiosemicarbazide for anti-fungal activity,” Arabian Journal of Chemistry, 2013.
[40]
V. Ravichandran, S. Mohan, and K. S. Kumar, “Synthesis and antimicrobial activity of Mannich bases of isatin and its derivatives with 2-[(2,6-dichlorophenyl)amino]phenylacetic acid,” ARKIVOC, vol. 2007, no. 14, pp. 51–57, 2007.
[41]
U. Yunus, M. H. Bhatti, N. Rahman, N. Mussarat, S. Asghar, and B. Masood, “Synthesis, characterization, and biological activity of novel Schiff and Mannich bases of 4-amino-3-(N-phthalimidomethyl)-1,2,4-triazole-5-thione,” Journal of Chemistry, vol. 2013, Article ID 638520, 8 pages, 2013.
[42]
R. Babbar, D. P. Pathak, N. Jain, and S. Jain, “Synthesis and anti-inflammatory activity of Mannich bases of Nicotinamide with diclofenac and mefenamic acid,” Der Pharma Chemica, vol. 4, no. 5, pp. 2024–2028, 2012.
[43]
P. Lohitha, D. Giles, C. Sreedhar et al., “Synthesis and pharmacological evaluation of schiff's and Mannich bases of indole derivatives,” RUGHS Journal of Pharmaceutical Sciences, vol. 1, no. 1, pp. 70–78, 2011.
[44]
K. V. Sujith, J. N. Rao, P. Shetty, and B. Kalluraya, “Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety,” European Journal of Medicinal Chemistry, vol. 44, no. 9, pp. 3697–3702, 2009.
[45]
K. K. Sivakumar, A. Rajasekaran, P. Senthilkumar, and P. P. Wattamwar, “Conventional and microwave assisted synthesis of pyrazolone Mannich bases possessing anti-inflammatory, analgesic, ulcerogenic effect and antimicrobial properties,” Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 13, pp. 2940–2944, 2014.
[46]
R. Rita and P. Shrivastva, “Synthesis and characterization of some N-Mannich bases as potential antimicrobial, anthelmintic and insecticidal agents,” Chemical Science Transaction, vol. 1, no. 2, pp. 431–439, 2012.
[47]
K. R. Raju, A. Guru Prasad, B. Kumar, L. Rao, and K. R. Ravindranath, “Synthesis and medicinal evaluation of Mannich bases carrying azetidinone moiety,” Journal of Clinical and Analytical Medicine, pp. 1–5, 2014.
[48]
N. S. Pandeya and N. Rajput, “Synthesis and anticonvulsant activity of various Mannich and Schiff bases of 1,5-benzodiazepines,” International Journal of Medicinal Chemistry, vol. 2012, Article ID 237965, 10 pages, 2012.
[49]
A. A. Kulkarni, S. B. Wankhede, N. D. Dhawale, P. B. Yadav, V. V. Deore, and I. D. Gonjari, “Synthesis, characterization and biological behavior of some Schiff's and Mannich base derivatives of Lamotrigine,” Arabian Journal of Chemistry, 2013.
[50]
M. Malhotra, M. Arora, A. Samad, K. Sahu, P. Phogat, and A. Deep, “Synthesis and evaluation of some novel derivatives of 2- propoxybenzylideneisonicotinohydrazide for their potential antimicrobial activity,” Journal of the Serbian Chemical Society, vol. 77, no. 5, pp. 589–597, 2012.
[51]
G. Hua, T. Caoa, H. Wenlong, et al., “Design, synthesis and antitumor activities of fluoroquinolone C-3 heterocycles ( IV): S-triazole Schiff-Mannich bases derived from ofloxacin,” Acta Pharmaceutica Sinica B, vol. 2, no. 3, pp. 312–317, 2012.
[52]
Y. Ivanova, G. Momekov, O. Petrov, M. Karaivanova, and V. Kalcheva, “Cytotoxic Mannich bases of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones,” European Journal of Medicinal Chemistry, vol. 42, no. 11-12, pp. 1382–1387, 2007.
[53]
R. M. Kumbhare, K. Vijay Kumar, M. J. Ramaiah et al., “Synthesis and biological evaluation of novel Mannich bases of 2-arylimidazo[2,1-b]benzothiazoles as potential anti-cancer agents,” European Journal of Medicinal Chemistry, vol. 46, no. 9, pp. 4258–4266, 2011.
[54]
M. Malhotra, R. Sharma, M. Sanduja, R. Kumar, E. Jain, and A. Deep, “Synthesis, characterization and evaluation of Mannich bases as potent antifungal and hydrogen peroxide scavenging agents,” Acta Poloniae Pharmaceutica: Drug Research, vol. 69, no. 2, pp. 355–361, 2012.
[55]
P. C. Jagadish, N. Soni, and A. Verma, “Design, synthesis, and in vitro antioxidant activity of 1,3,5-trisubstituted-2-pyrazolines derivatives,” Journal of Chemistry, vol. 2013, Article ID 765768, 6 pages, 2013.
[56]
K. Chakkaravarthi, K. Gokulakrishnan, T. Suman, and D. Tamilvendan, “Synthesize, spectral, antimicrobial and antioxidant studies of diamide mannich base derivatives,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 1, pp. 492–495, 2013.
[57]
L. Ma, Y. Xiao, C. Li et al., “Synthesis and antioxidant activity of novel Mannich base of 1,3,4-oxadiazole derivatives possessing 1,4-benzodioxan,” Bioorganic and Medicinal Chemistry, vol. 21, no. 21, pp. 6763–6770, 2013.
[58]
C. K. Kumar and S. N. Pandeya, “Synthesis, characterization and analgesic activity of various pyridine derivatives,” International Journal of Ayurveda and Pharmacy, vol. 2, no. 6, pp. 1763–1767, 2011.
[59]
M. A. Ali and M. Shaharyar, “Oxadiazole mannich bases: synthesis and antimycobacterial activity,” Bioorganic and Medicinal Chemistry Letters, vol. 17, no. 12, pp. 3314–3316, 2007.
[60]
D. Sriram, P. Yogeeswari, and S. P. Reddy, “Synthesis of pyrazinamide Mannich bases and its antitubercular properties,” Bioorganic and Medicinal Chemistry Letters, vol. 16, no. 8, pp. 2113–2116, 2006.
[61]
T. Taj, R. R. Kamble, T. M. Gireesh, and R. K. Hunnur, “Facile syntheses of Mannich bases of 3-[p-(5-arylpyrazolin-3-yl)phenyl] sydnones, as anti-tubercular and anti-microbial agents, under ionic liquid/tetrabutylammonium bromide catalytic conditions,” Journal of the Serbian Chemical Society, vol. 76, no. 8, pp. 1069–1079, 2011.
